Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
about
MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosisMolecular carcinogenesis of canine mammary tumors: news from an old diseaseIn Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine LymphocytesIdentification of prognostic factors in canine mammary malignant tumours: a multivariable survival studyMolecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry.Ki-67 protein expression and tumor associated inflammatory cells (macrophages and mast cells) in canine colorectal carcinoma.Retrospective study and immunohistochemical analysis of canine mammary sarcomas.3D chick embryo chorioallantoic membrane model as an in vivo model to study morphological and histopathological features of feline fibrosarcomas.Factors influencing the incidence and prognosis of canine mammary tumours.Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomasCellular proliferation in tumors: a review of methods, interpretation, and clinical applications.Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic.Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases.Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366Immunohistochemical quantification of the cobalamin transport protein, cell surface receptor and Ki-67 in naturally occurring canine and feline malignant tumors and in adjacent normal tissuesPrognostic and predictive markers in canine tumours: rationale and relevance. A review.Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction.Canine mammary tumours, an overview.Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas.Expression of p53 protein, Jaagsiekte sheep retrovirus matrix protein, and surfactant protein in the lungs of sheep with pulmonary adenomatosis.Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland.Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease.The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma.Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index.Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.PCNA and grade in 13 canine oral squamous cell carcinomas: association with prognosis.Immunocytochemical detection of Ki-67 in Diff-Quik-stained cytological smears of canine mammary gland tumours.Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma.Clinocopathologic and immunohistochemical findings of multiple genital leiomyomas and mammary adenocarcinomas in a bitch.Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
P2860
Q28213325-BA2C3CBD-EDBF-4EE5-A106-79187F8D11C1Q28300581-F79CB29C-8655-4769-B934-E66352E2E472Q28551762-434B9BDB-E883-4B6A-A387-AB189A32D118Q31110389-69811B20-8E08-46CC-A58B-A3F22BCDA4DFQ33527137-065BBAAC-0E99-4E38-97BD-58E5542A08CEQ33582044-B97EE22F-7227-4B65-B67A-C8B82F20C3FDQ33643473-A15A32F9-F850-49E2-BA67-9EE57BE417BDQ33837735-9A410AEC-6B20-41E5-9C29-6B1F73FC1B19Q34025189-78B48548-5ABE-4DFB-B2BE-F1BE4F3F79EDQ34140326-01A42790-3DA5-419E-84C4-3A8B2A8B7651Q34316199-458820BA-06AD-4944-83D3-7113A5667D48Q34497188-029F4A30-2F28-4BB6-8578-1D4317AA220FQ34677862-7837A3F4-C1EE-432A-9D59-A147E016FC73Q35119025-3C3718FE-C35F-4E32-8F14-ADB9233F022DQ35217289-8C5D3540-710C-402D-96F5-1830D2339A29Q35273633-07CDB6A0-4DB8-4D9E-AA3D-EE36E5C3E6F5Q36196363-F57F58B2-CEB3-4CBC-8FAC-D7D9BF2A2B39Q37595420-F937AFB4-BED2-48A1-B401-01E20C321884Q37885436-4FD8FA8A-F8A8-4306-A468-DC7BE03BAF31Q38716160-2C13B167-59EE-4850-AFD1-E1BB61951037Q40034698-8D6D2646-3074-4C42-B7A0-DC54751A5568Q40093120-FD520DC0-AD37-4916-9AAE-C51FA1980DCFQ40832378-E799ABE5-1D72-427D-9480-F27BFBB99A5CQ42452843-1C99203C-E519-4BC9-B404-EA2A973A13A2Q43182615-58AB3ABD-F901-46B5-AAC9-4FD9C87F731FQ43247993-28EA1294-3E06-49E1-AE55-C96DE4238C1DQ43989152-B0381733-55CD-4338-B949-A0C603B9E91EQ44055222-C59CE34B-059A-4B58-AB1A-679CEF59236FQ44444342-949F9624-C9A1-4165-A24E-6BA84AEF0108Q44817356-E0CCBC00-0B47-4F84-821F-1D43D1795E0FQ45309233-EF097AA8-E9A4-43C7-8821-F3B78ADE6475Q46113895-779D4998-CF4E-4ABC-840B-50E27468C836Q46271916-72BDAC16-C868-426B-A9B8-47FD2E99360AQ46881230-E5D147EB-FEB1-4E92-AE03-8018DFF653A3Q47984572-A448C875-82ED-464B-89CF-E2D155164116Q48243711-9587B0F7-E924-4412-BC96-136C90100FEEQ50444542-07BAE839-6F2D-44F4-88CB-9024E15A0F9AQ51202641-6AE5F325-12D9-4050-9C2E-E803406C65F1Q51717717-4FC3544B-984A-4C69-865D-05054DA74306Q53073419-77733C19-31FB-4E6B-AB7A-CA791D201D57
P2860
Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Immunohistochemical detection ...... ical and pathologic variables.
@en
Immunohistochemical detection ...... ical and pathologic variables.
@nl
type
label
Immunohistochemical detection ...... ical and pathologic variables.
@en
Immunohistochemical detection ...... ical and pathologic variables.
@nl
prefLabel
Immunohistochemical detection ...... ical and pathologic variables.
@en
Immunohistochemical detection ...... ical and pathologic variables.
@nl
P2093
P2860
P1476
Immunohistochemical detection ...... nical and pathologic variables
@en
P2093
D Pérez-Alenza
P2860
P304
P356
10.1177/104063879801000303
P50
P577
1998-07-01T00:00:00Z